Fundamentals and stats
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ZLDAF has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company